Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor

Last updated: January 6, 2010
Sponsor: Microlife
Overall Status: Completed

Phase

N/A

Condition

Chest Pain

Atrial Fibrillation

Cardiac Disease

Treatment

N/A

Clinical Study ID

NCT00861354
tripps2
  • Ages > 21
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study assess the accuracy of a blood pressure monitor designed to detect atrial fibrillation. Subjects use the blood pressure monitor on a daily basis for 30 days and compare the readings to an ECG done at the same time.

Eligibility Criteria

Inclusion

Inclusion Criteria: any of the following

  • age 65 or older

  • hypertension

  • diabetes mellitus

  • congestive heart failure

  • previous stroke

Exclusion

Exclusion Criteria:

  • permanent pacemaker

  • impalantable defibrillator

Study Design

Total Participants: 150
Study Start date:
March 01, 2009
Estimated Completion Date:
September 30, 2009

Connect with a study center

  • Joseph Wiesel, MD medical office

    Flushing, New York 11355
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.